• 1. Essential effect of the electrolyte on the mechanical and chemical degradation of LiNi0.8Co0.15Al0.05O2 cathodes upon long-term cycling??
  Xiaoming Liu,Zachary D. Hood,Wangda Li,Donovan N. Leonard,Arumugam Manthiram,Miaofang Chi J. Mater. Chem. A, 2021,9, 2111-2119
• 2. Emerging 2D hybrid nanomaterials: towards enhanced sensitive and selective conductometric gas sensors at room temperature
  Hanie Hashtroudi,Ian D. R. Mackinnon J. Mater. Chem. C, 2020,8, 13108-13126
• 3. Evolution and characterization of a benzylguanine-binding RNA aptamer?
  J. Xu,T. J. Carrocci,A. A. Hoskins Chem. Commun., 2016,52, 549-552
• 4. Evidence of CO2 molecule acting as an electron acceptor on a nanoporous metal–organic-framework MIL-53 or Cr3+(OH)(O2C–C6H4–CO2)?
  Alexandre Vimont,Arnaud Travert,Philippe Bazin,Jean-Claude Lavalley,Marco Daturi,Christian Serre,Gérard Férey,Sandrine Bourrelly,Philip L. Llewellyn Chem. Commun., 2007, 3291-3293
• 5. Evidence for the intrinsic nature of band-gap states electrochemically observed on atomically flat TiO2(110) surfaces?
  Shintaro Takata,Yoshihiro Miura Phys. Chem. Chem. Phys., 2014,16, 24784-24789

• Solvents and Organic Chemicals Organic Compounds Benzenoids Benzene and substituted derivatives Benzylamines 2-benzylaminopyridines

Introduction to N-Benzyl-5-bromo-3-methylpyridin-2-amine (CAS No. 1219976-47-2)

N-Benzyl-5-bromo-3-methylpyridin-2-amine is a significant compound in the realm of pharmaceutical chemistry, characterized by its unique structural and chemical properties. This compound, identified by the CAS number 1219976-47-2, has garnered attention due to its potential applications in the development of novel therapeutic agents. The presence of both bromine and methyl substituents on the pyridine ring enhances its reactivity, making it a valuable intermediate in synthetic organic chemistry.

The molecular structure of N-Benzyl-5-bromo-3-methylpyridin-2-amine consists of a pyridine core substituted with a benzyl group at the 2-position, a bromine atom at the 5-position, and a methyl group at the 3-position. This specific arrangement imparts distinct electronic and steric properties, which are crucial for its role in drug design and discovery. The benzyl group, in particular, serves as a protective group and can be easily removed under specific conditions, allowing for further functionalization.

In recent years, there has been a surge in research focused on developing small molecule inhibitors for various therapeutic targets. The compound N-Benzyl-5-bromo-3-methylpyridin-2-amine has emerged as a key intermediate in the synthesis of such inhibitors. Its versatility in undergoing various chemical transformations makes it an attractive candidate for medicinal chemists seeking to develop new drugs. For instance, it can be used to construct more complex scaffolds through cross-coupling reactions, such as Suzuki-Miyaura or Buchwald-Hartwig couplings.

One of the most compelling aspects of N-Benzyl-5-bromo-3-methylpyridin-2-amine is its potential in fragment-based drug discovery. Fragment-based approaches involve identifying small, low-molecular-weight compounds that bind to the target protein with moderate affinity. These fragments can then be optimized through iterative rounds of modification to produce potent inhibitors. The structural features of N-Benzyl-5-bromo-3-methylpyridin-2-amine, including its aromatic system and substituents, make it an ideal candidate for such strategies.

The bromine atom at the 5-position of the pyridine ring is particularly noteworthy, as it provides a handle for further functionalization via palladium-catalyzed cross-coupling reactions. These reactions are widely used in pharmaceutical synthesis to introduce diverse functional groups into complex molecules. For example, Suzuki-Miyaura coupling can be employed to attach aryl or heteroaryl groups, while Buchwald-Hartwig coupling allows for the introduction of amine functionalities. Such modifications can significantly enhance the binding affinity and selectivity of drug candidates.

Recent studies have highlighted the importance of N-Benzyl-5-bromo-3-methylpyridin-2-amine in the development of kinase inhibitors. Kinases are enzymes that play critical roles in cell signaling pathways and are often implicated in various diseases, including cancer. By targeting specific kinases with small molecule inhibitors, it is possible to modulate these pathways and achieve therapeutic effects. The structural features of N-Benzyl-5-bromo-3-methylpyridin-2-amine make it a promising candidate for designing such inhibitors.

The benzyl group at the 2-position not only serves as a protecting group but also contributes to the overall solubility and bioavailability of drug candidates. In addition, the methyl group at the 3-position can influence the electronic properties of the pyridine ring, thereby affecting its interactions with biological targets. These features make N-Benzyl-5-bromo-3-methylpyridin-2-amine a versatile building block for medicinal chemists.

In conclusion, N-Benzyl-5-bromo-3-methylpyridin-2-am ine (CAS No. 1219976- 47- 2) is a compound with significant potential in pharmaceutical research and drug development. Its unique structural features and reactivity make it an invaluable intermediate for constructing novel therapeutic agents. As research continues to advance, it is likely that this compound will play an even greater role in the discovery and development of new drugs.

• 2098070-20-1(2-(3-(Pyridin-3-yl)-1H-pyrazol-1-yl)acetimidamide)
• 2680771-01-9(4-cyclopentyl-3-{(prop-2-en-1-yloxy)carbonylamino}butanoic acid)
• 1444113-98-7(N-(3-cyanothiolan-3-yl)-2-[(2,2,2-trifluoroethyl)sulfanyl]pyridine-4-carboxamide)
• 332062-08-5(Fmoc-S-3-amino-4,4-diphenyl-butyric acid)
• 1270529-38-8(1,2,3,4,5,6-Hexahydro-[2,3]bipyridinyl-6-ol)
• 941977-17-9(N'-(3-chloro-2-methylphenyl)-N-2-(dimethylamino)-2-(naphthalen-1-yl)ethylethanediamide)
• 2138166-62-6(2,2-Difluoro-3-[methyl(2-methylbutyl)amino]propanoic acid)
• 89640-58-4(2-Iodo-4-nitrophenylhydrazine)
• 1449132-38-0(3-Fluoro-5-(2-fluoro-5-methylbenzylcarbamoyl)benzeneboronic acid)
• 2034271-14-0(2-(1H-indol-3-yl)-N-{[6-(thiophen-2-yl)-[1,2,4]triazolo[4,3-b]pyridazin-3-yl]methyl}acetamide)